These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 15703362

  • 21. Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
    L'homme RF, Kabamba D, Ewings FM, Mulenga V, Kankasa C, Thomason MJ, Walker AS, Chintu C, Burger DM, Gibb DM.
    AIDS; 2008 Mar 12; 22(5):557-65. PubMed ID: 18316996
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetic profiling and bioequivalence evaluation of 2 lamivudine tablet formulations after single oral administration in healthy human Indian volunteers.
    Narang VS, Lulla A, Malhotra G, Purandare S.
    J Acquir Immune Defic Syndr; 2005 Apr 15; 38(5):566-9. PubMed ID: 15793367
    [Abstract] [Full Text] [Related]

  • 25. Bioequivalence of two lamivudine tablet formulations.
    Santos-Magalhães NS, Pontes A, Cavalcante RM, Costa RM, Rangel FA, Guimarães MI, de Carvalho JN, de Souza SD, de Oliveira HM, Esteves IL, Ramalho MS, Vieira SL, Alves AJ.
    Arzneimittelforschung; 2001 Apr 15; 51(4):310-4. PubMed ID: 11367872
    [Abstract] [Full Text] [Related]

  • 26. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.
    Clin Ther; 2009 Feb 15; 31(2):399-410. PubMed ID: 19302912
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B, Riek M, Holmes B, Grange S.
    Antivir Ther; 2005 Feb 15; 10(7):803-10. PubMed ID: 16312177
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.
    Byakika-Kibwika P, Lamorde M, Kalemeera F, D'Avolio A, Mauro S, Di Perri G, Ryan M, Mayanja-Kizza H, Khoo S, Back D, Boffito M, Merry C.
    J Antimicrob Chemother; 2008 Nov 15; 62(5):1113-7. PubMed ID: 18641036
    [Abstract] [Full Text] [Related]

  • 31. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
    Estrela Rde C, Salvadori MC, Suarez-Kurtz G.
    Rapid Commun Mass Spectrom; 2004 Nov 15; 18(10):1147-55. PubMed ID: 15150840
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.
    Chokephaibulkit K, Plipat N, Cressey TR, Frederix K, Phongsamart W, Capparelli E, Kolladarungkri T, Vanprapar N.
    AIDS; 2005 Sep 23; 19(14):1495-9. PubMed ID: 16135903
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
    Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, Ferrier A, Chintu C, Walker AS, Gibb DM, Burger DM.
    AIDS; 2012 Sep 10; 26(14):1795-800. PubMed ID: 22739394
    [Abstract] [Full Text] [Related]

  • 35. Bioequivalence study of two nevirapine tablet formulations in human-immunodeficiency-virus-infected patients.
    Tarinas A, Tápanes RD, González D, Ferrer G, Abreu D, Pérez J.
    Farm Hosp; 2007 Sep 10; 31(3):165-8. PubMed ID: 17941755
    [Abstract] [Full Text] [Related]

  • 36. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
    Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W.
    Clin Infect Dis; 2007 Feb 01; 44(3):447-52. PubMed ID: 17205457
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W.
    Clin Ther; 2004 Dec 01; 26(12):2015-25. PubMed ID: 15823765
    [Abstract] [Full Text] [Related]

  • 40. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.
    Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liégeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngolé E, Delaporte E.
    Lancet; 2004 Dec 01; 364(9428):29-34. PubMed ID: 15234853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.